Cabergoline’s mechanism of action and introduction to applicable diseases
Cabergoline is an oral dopamine receptor agonist that mainly works by selectively activating dopamine D2 receptors in the brain. It inhibits the secretion of prolactin (Prolactin) in the anterior lobe of the pituitary gland, thereby regulating hormone balance in the body. Due to its long half-life and good tolerability, cabergoline is widely used clinically to treat a variety of diseases related to prolactin abnormalities.
The main mechanism of action of cabergoline is to inhibit the synthesis and release of prolactin by stimulating dopamineD2 receptors. Prolactin is a hormone secreted by the pituitary gland, involved in breast development and milk secretion, and also affects the menstrual cycle and reproductive function. When prolactin levels in the body are abnormally elevated, it may lead to problems such as menstrual disorders, infertility, galactorrhea in women, and sexual dysfunction in men. Cabergoline effectively relieves these symptoms by reducing prolactin levels.

In terms of indications, cabergoline is mainly used to treat clinical symptoms caused by hyperprolactinemia, such as excessive prolactin secretion caused by pituitary microadenomas or macroadenomas. In addition, it is also used to treat dopamine deficiency symptoms in Parkinson's disease, although this is not its preferred indication. For some patients, cabergoline can also improve vision impairment or headaches caused by pituitary tumors by reducing the size of the tumors.
In addition, cabergoline is used for atypical purposes, such as regulating fertility problems, treating sexual dysfunction, and assisting in the treatment of certain endocrine diseases. Its good efficacy and relatively low side effects make it one of the first-choice drugs for clinical treatment of prolactin abnormalities. However, due to the characteristics of the drug and individual differences among patients, it is necessary to strictly follow the doctor's instructions when using it, and regularly monitor hormone levels and related indicators to ensure that the treatment is safe and effective.
Reference materials:https://my.clevelandclinic.org/health/drugs/20863-cabergoline-tablets
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)